LCID Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Lucid Group Inc (LCID) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the company shows some growth potential through partnerships and new product launches, its financials remain weak, and there are mixed analyst ratings with significant downside risks. Given the lack of strong trading signals and the investor's preference for long-term stability, it is better to hold off on investing in LCID for now.
The MACD is positive at 0.0418, indicating slight bullish momentum, but it is contracting. RSI is neutral at 41.67, showing no clear overbought or oversold signal. Moving averages are converging, suggesting indecision in the market. The stock is trading near its support level (S1: 9.812) and below its pivot point (10.263), indicating limited upward momentum.
Revenue surged 122% YoY in Q4 2025, driven by strong demand for the Lucid Gravity SUV.
Partnerships with Uber and Nuro to supply 20,000 SUVs over six years could boost sales.
The upcoming Lucid Earth model, priced below $50,000, aims to penetrate the mainstream market.
Rising oil prices due to geopolitical tensions may increase EV demand.
Persistent high negative gross margin (-80.71%) and large operating losses.
Mixed analyst ratings with price targets ranging from $10 to $17, reflecting uncertainty.
Increased competition from Rivian and Tesla in the EV market.
High price-to-sales ratio suggests caution until consistent sales growth is demonstrated.
In Q4 2025, revenue increased by 122.94% YoY to $522.7 million, but net income remained negative at -$1.28 billion, up 101.64% YoY. EPS improved to -3.97, up 77.23% YoY. Gross margin dropped to -80.71%, reflecting ongoing profitability challenges.
Analyst ratings are mixed: Citi initiated a Buy rating with a $17 price target, citing a positive inflection point. However, BofA reinstated coverage with an Underperform rating and a $10 price target, citing muted EV adoption and regulatory challenges. Cantor Fitzgerald and Baird lowered price targets to $14 and $13, respectively, citing weak production guidance and high negative gross margins.
